Epi Info æ¥æ¬èªç ç«å¦èª¿æ»ã®ä¼ç»ï¼å®æ½ï¼è§£æï¼å ±åã¾ã§ã®å ¨ã¦ãã¢ã·ã¹ãããã½ããã§ï¼ 調æ»ç¥¨ä½æï¼ãã¼ã¿å ¥åï¼ãã¼ã¿è§£æï¼å°å³ä½æï¼å ±åæ¸ä½æãè¡ãã¾ãï¼ ã¾ããã¥ã¼ããªã¢ã«ãå å®ãã¦ãã¦ï¼é£ä¸æ¯äº ä¾ï¼ææçäºä¾ï¼ãµã¼ãã¤ã©ã³ã¹äºä¾ãå¦ã¹ã¾ãï¼ ï¼£ï¼¤ï¼£ ã§ã¯ï¼ç«å¦ç ä¿®ã«ï¼Epi Info ãæ´»ç¨ãã¦ãã¦ï¼ã¾ãä¸çä¸ã®å½ãå©ç¨åºæ¥ãããã« åå½èªå¯¾å¿ãå¯è½ãªã·ã¹ãã ãæä¾ãã¦ãã¾ãï¼ 2012å¹´7æ30æ¥ã« EpiInfoTM 3.5.4(2012/07/30) ããªãªã¼ã¹ããã¾ããï¼è±èªçã¯3.5.4ã§ããï¼å¼ãç¶ãæ¥æ¬èªããã3.5.3ãé©ç¨ãã ããï¼ XPã«ã¯ï¼Epi info3.5.3 XPæ¥æ¬èªããã jpatchXP353.exe(2012/04/25)ãã使ãä¸ããï¼ Vista, Windows 7 ã«ã¯ï¼Epi info3.5.3 VistaWin7æ¥æ¬èªããã
This site is devoted to the life and times of Dr. John Snow (1813-1858), a legendary figure in the history of public health, epidemiology and anesthesiology. Click with your left mouse key to see and hear the material or and to see the material. The maps and narrations present the Snow story in place and time. The following articles describe the intent of the John Snow site and comment about his l
Food and Drug Administration Amendments Act (FDAAA) ç»é²èª¿æ»ãClinicalTrials.govãé¨åã®è¨åºè©¦é¨çµæå ±å義åï¼ãã©ã¤ã¢ã«çµäºå¾1年以å ï¼ã³ã³ãã©ã¤ã¢ã³ã¹èª¿æ» Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study Published 3 Jan 2012 BMJ 2012; 344 doi: 10.1136/bmj.d7373 (Published 3 January 2012) Cite this as: BMJ 2012;344:d7373 ClinicalTrials.gov registryãä»å ¥ãã©ã¤ã¢ã«83â579 ã¨ã³ããªã¼ããã¡5642ãtimesc
Health InfoScape from MIT Senseable Cities and GE aims to create new ways of understanding human health in the United States. By analyzing data from over 7.2 million anonymized electronic medical records, taken from across the country, we are seeking to uncover statical relationships between space, geography and health. We often have a tendency to think of illness as an isolated event, but our fir
ä»æ¥ãã使ãã å»ççµ±è¨å¦è¬åº§ ãLesson3ã ãµã³ãã«ãµã¤ãºã¨ãã¯ã¼è¨ç® æ°è°·æ©ï¼ç±³å½ã´ã¡ã³ãã¼ãã«ã大å¦åææã»å»ççµ±è¨å¦ï¼ ï¼2933å·ããã¤ã¥ãï¼ è¨åºç 究ãè¡ãéï¼ãããã¯è«æçãèªãéï¼çµ±è¨å¦ã®ç¥èãæã¤ãã¨ã¯å¿ é ã§ãã æ¬é£è¼ã§ã¯ï¼çµ±è¨å¦ãæ¬é ãããä¸å ã¨ãªã£ã¦ããæ°å¼ããªãã¹ã使ããªãå½¢ã§ï¼è«æãªã©ã«å¤ç¨ãããçµ±è¨ï¼å»å¦ç 究è ãé¥ããã¡ãªãã¤ã³ãã¨ããã«å¯¾ããèãæ¹ã«ã¤ãã¦ç´¹ä»ãï¼è¨åºç 究åéã®ãªãã©ã·ã¼ã®åä¸ããããã¾ãã ç 究è¨ç»ã®çå®æã«ï¼ãã¼ã¿ãã©ããããã®æ°ã®è¢«é¨è ããéãã¦ããã°ããã®ãé ãæ©ã¾ãããï¼å®é¨ãã¦ã¹ã1群10å¹ã«ããã®ãï¼5å¹ã«ããã®ãã§è¿·ã£ãããããã¨ã¯ãªãã§ããããï¼ ä»¥åæ¬ç´ã«å¯ç¨¿ããéï¼ç¬¬2912å·ï¼ã«è§¦ããããã«ï¼ãµã³ãã«æ°ãå¤ããã°å¤ãã»ã©è§£æã®ç²¾åº¦ãä¸ããï¼ããã«ä¼´ãPå¤ã¯å°ãããªãã¾ãã極端ã«è¨ãã°ï¼è¨åºçã«æå³ã®ãªãã©ããªã«å°
Jeanããããã³ã¡ã³ããããã ãã¾ãããé常ãåã¯å人çãªå»çåé¡ã«ã¤ãã¦ããã°ã§ã話ãããã¨ã¯ããã¾ããï¼ãã¾ããããªããã¨ãå¤ãããã§ãï¼ããããããã®ã話ã¯ä¸è¬çãªåé¡ãå«ãã§ããã®ã§ãããã¦ããã§ã話ãã¾ãã ããã ããã質åã¯ã ãåå®®é ¸çã¯ã¯ãã³æåãå¥æ©ã«SLEãçºçãã女ã®åããã¾ãããã¾ããªã±ã¼ã¹ã§ããããã©ãã¢ã¸ã¥ãã³ãã¨ããå½±é¿ããã®ã§ããããã ã§ãããçµè«ããç³ãä¸ããã¨ã ãã®ã¯ã¯ãã³ï¼ã¢ã¸ã¥ãã³ãå«ãï¼ãSLEã®åå ã§ã¯ãªãã¨æãã¾ããå°ãªãã¨ããã®å¯è½æ§ã¯ä½ãã§ãã ã§ã¯ããã®çç±ã説æãã¾ãã ã¯ã¯ãã³ãæã£ãå¾ããããããªç æ°ã«ããã人ããã¾ããSLEã®ãããªèªå·±å ç«ç¾æ£ã¨ããã°ã«ã¼ãã®ç æ°ã«ãªã人ãç¥ããã¦ãã¾ããããããåå®®é ¸çã¯ã¯ãã³ãæã£ãå¾ã§ãã¹ãã£ã«ç ã¨ããITPã¨å¼ã°ããèªå·±å ç«ç¾æ£ã«ãªã£ãã¨ããå ±åãåºã¦ãã¾ãã ã¯ã¯ãã³ãæã£ãå¾ç æ°
ç°¡ææ¤æ»ã¯ããã¹ãã§ã¯ãªãï¼ åç§ç°å¸ã®ç é¢ã§ã¤ã³ãã«ã¨ã³ã¶ã®éå£ææããã£ããç°¡ææ¤æ»ã§ã¯é°æ§ã ã£ããæ»äº¡ããæ£è ãããã¨å ±éããã*1ãã¤ã³ãã«ã¨ã³ã¶è¿ é診æãããã®æ度ã¯é«ããªããã¤ã¾ããã¤ã³ãã«ã¨ã³ã¶ã«ææãã¦ãã¦ãæ¤æ»çµæã§é°æ§ã¨åºããããã¨ã¯ããç¥ããã¦ãããããããæ¤æ»ã¨åæ§ã«ãã¤ã³ãã«ã¨ã³ã¶ã®ç°¡ææ¤æ»ã¯æ度ã»ç¹ç°åº¦ãç解ã®ä¸ã«ä½¿ãã¹ãã§ãã*2ãå½ããåã®è©±ãããããã¾ãã«ãã¤ã³ãã«ã¨ã³ã¶ã®æ£è ã«å¯¾ãã¦ãç°¡ææ¤æ»ãããã¹ãã§ã¯ãªããç°¡ææ¤æ»ãããæå³ã¯ä½ããªãã¨èª¤è§£ãã¦ãã人ãããã â Open ããã°: â ç°¡ææ¤æ»ã«ããæ»è å¢å *3 è¦ããã«ãç°¡ææ¤æ»ãããæå³ã¯ãä½ããªãã ã» æ¤æ»ã§é½æ§ãªãã°ãâãæã¤ã³ãã«ã¨ã³ã¶è¬ã®æä¸ ã» æ¤æ»ã§é°æ§ãªãã°ãâãæã¤ã³ãã«ã¨ã³ã¶è¬ã®æä¸ ï¼æ§åè¦ãã¯ééããï¼ ã¤ã¾ããã©ã£ã¡ã¿ã¡ããæã¤ã³ãã«ã¨ã³ã¶è¬ã®æä¸ãã§ãããæä¸ãããå¦
ã©ã³ãã³ã°
é害
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}